Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
6,440.00
+170.00 (2.71%)
Last updated: Nov 5, 2025, 12:14 PM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 153.24 billion as of November 5, 2025. Its market cap has decreased by -23.05% in one year.
Market Cap
153.24B
Enterprise Value
260.74B
Revenue
243.45B
Ranking
n/a
PE Ratio
369.85
Stock Price
6,440.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 153.24B, a decrease of -81.28%. That is a compound annual growth rate of -14.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 149.90B | 0.80% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | 390.88B | 97.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.84T |
| ALTEOGEN | 29.36T |
| SK Biopharmaceuticals | 9.42T |
| Yuhan | 9.01T |
| HLB Co., Ltd. | 7.03T |
| Peptron | 6.33T |
| ABL Bio | 6.13T |